Fedde van der Graaf

Exclusion of deep venous thrombosis with D-dimer testing--comparison of 13 D-dimer methods in 99 outpatients suspected of deep venous thrombosis using venography as reference standard.

Fedde van der Graaf, HW Van den Borne, M van der Kolk et al. · PubMed · 2000 · 192 citations

Deep Venous Thrombosis, Diagnosis, Pathology +17

Inflammatory response in the acute phase of deep vein thrombosis

Edith M. Roumen-Klappe, Martin den Heijer, Stan Van Uum et al. · Journal of Vascular Surgery · 2002 · 170 citations · Full text

Inflammation, Thrombosis, Thrombopoiesis +10

Determination of dabigatran, rivaroxaban and apixaban by ultra‐performance liquid chromatography – tandem mass spectrometry (UPLC‐MS/MS) and coagulation assays for therapy monitoring of novel direct oral anticoagulants

E.M.H. Schmitz, Kjm Kristel Boonen, D.J.A. van den Heuvel et al. · Journal of Thrombosis and Haemostasis · 2014 · 169 citations · Full text

Thrombosis, Therapeutic Drug Monitoring, Therapy Monitoring +13

Inactivation of kallikrein in human plasma.

Fedde van der Graaf, J A Koedam, Bonno N. Bouma · Journal of Clinical Investigation · 1983 · 161 citations · Full text

Kallikrein Inactivation, Inhibitory Activity, Biochemistry +15

Exclusion of Deep Venous Thrombosis with D-Dimer Testing

Henk van den Borne, Marion van der Kolk, Piet de Wild et al. · Thrombosis and Haemostasis · 2000 · 149 citations

Deep Venous Thrombosis, Diagnosis, Pathology +16